Cargando…
Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies
Anthracyclines are important for the treatment of gynecological malignancies, but their effects are modest, and one of the major reasons is the lack of a tumor-targeting property. To overcome this drawback, a poly (hydroxypropyl meta-acrylamide) conjugated with tetrahydropyraryl doxorubicin (P-THP)...
Autores principales: | Yanazume, Shintaro, Fang, Jun, Islam, Rayhanul, Gao, Shanghui, Kobayashi, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143157/ https://www.ncbi.nlm.nih.gov/pubmed/35629236 http://dx.doi.org/10.3390/jpm12050814 |
Ejemplares similares
-
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021) -
Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines
por: Šubr, Vladimír, et al.
Publicado: (2022) -
Synthesis and therapeutic effect of styrene–maleic acid copolymer-conjugated pirarubicin
por: Tsukigawa, Kenji, et al.
Publicado: (2015) -
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
por: Tavares, Marina R., et al.
Publicado: (2021) -
Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis
por: Wang, Dong, et al.
Publicado: (2007)